The FDA filed a lawsuit accusing Med Prep Consulting, a New Jersey compounding pharmacy, of safety violations. The agency is seeking to permanently shut down the company as part of recent moves to increase scrutiny of drug compounders. Several problems were listed by the FDA, including unsanitary conditions, the lack of appropriate tests for drug batches, and failure to maintain equipment.

Related Summaries